Name | Galanthamine hydrobromide |
Description | Galanthamine hydrobromide (Galantamine hydrobromide), a long-acting and centrally active AChE inhibitor (IC50:410 nM), is an allosteric potentiator at neuronal nicotinic ACh receptors. |
In vitro | Galanthamine has been demonstrated to have an IC50 of 14 nM and 15 nM on AChE in post-mortem human brain frontal cortex and the hippocampus region. Red-cell cholinesterase activity in blood samples from the neurosurgery patients is 10 times more strongly inhibited by Galanthamine in brain tissue samples. [1] Galanthamine (1 μM) activates single channels with conductance's of 18 and 30 pS in outside-out patches excised from dexamethasone mouse fibroblasts (M10 cells). [2] Galanthamine acts as noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma (PC12) cells. Galanthamine (50 μM) activates single-channel currents in outside-out patches excised from clonal PC12 cells. [3] |
In vivo | Galantamine significantly increases the number of living pyramidal neurons after ischemia-reperfusion injury. Galantamine significantly reduces TUNEL, active caspase-3, and SOD-2 immunoreactivity. The nicotinic antagonist mecamylamine blockes the protective effects of galantamine. The neuroprotective effects of galantamine are preserved even when first administered at 3 hours postischemia. [4] |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 60 mg/mL (162.92 mM), Heating is recommended. H2O : 7.4 mg/mL (20 mM)
|
Keywords | disease | neurodegenerative | Inhibitor | nAChR | Nicotinic acetylcholine receptors | Galantamine Hydrobromide | disease (AD) | Galanthamine hydrobromide | Cholinesterase (ChE) | acetylcholinesterase | inhibit | Galanthamine Hydrobromide | Galantamine | Alzheimer's | Galanthamine |
Inhibitors Related | Adiphenine hydrochloride | Nanofin | Forskolin | Ribavirin | Diethyltoluamide | Adenine | Choline chloride | Propoxur | Methyl tridecanoate | Trimethylammonium chloride |
Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Alkaloid Natural Product Library | Natural Product Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Natural Product Library for HTS | Bioactive Compounds Library Max |